Hainan Shuangcheng Pharmaceuticals Co. Ltd. | Ownership
Companies that own Hainan Shuangcheng Pharmaceuticals Co. Ltd.
HuaAn Fund Management Co., Ltd.
139,259
0.03%
-247,932
0%
12/31/2017
E Fund Management Co., Ltd.
122,753
0.03%
-47,700
0%
12/31/2017
Guotai Junan Allianz Fund Management Co., Ltd.
1,200
0%
0
0%
12/31/2017
Zhongrong Fund Management Co. Ltd.
0
0%
-6,000
0%
12/31/2017
China Southern Asset Management Co., Ltd.
0
0%
-331,800
0%
12/31/2017
JT Asset Management Co., Ltd.
0
0%
-131,280
0%
12/31/2017
Morgan Stanley Huaxin Fund Management Co., Ltd.
0
0%
-1,347,400
0%
12/31/2017
Chang Xin Asset Management Co., Ltd.
0
0%
-6,885,535
0%
12/31/2017
| Address |
No. 16 Xingguo Road
Haikou Hainan 570314
China
|
|
Employees
|
- |
| Website |
http://www.shuangchengmed.com |
| Updated |
07/08/2019 |
| Hainan Shuangcheng Pharmaceuticals Co., Ltd. engages in the manufacture and sale of chemically synthesized peptide drugs & APIs. It offers finished dosages and generic peptide active pharmaceutical ingredient. Its products include Thymalfasin, Levocarnitine, Clindamycin Hydrochloride, Thymopentin, Famotidine and Somatostatin for Injection. |
